Cargando…

Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents

We report 2 cases of Whipple disease (WD), previously diagnosed as seronegative polyarthritis and treated for several years with immunosuppressive agents, accordingly. Both cases had been treated over years with cDMARDs and bDMARDs. The first patient was a 48-year-old male, who developed a life-thre...

Descripción completa

Detalles Bibliográficos
Autores principales: Quartuccio, Luca, Giovannini, Ivan, Pizzolitto, Stefano, Scarpa, Maurizio, De Vita, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815603/
https://www.ncbi.nlm.nih.gov/pubmed/31737398
http://dx.doi.org/10.1155/2019/3410468
_version_ 1783463221597831168
author Quartuccio, Luca
Giovannini, Ivan
Pizzolitto, Stefano
Scarpa, Maurizio
De Vita, Salvatore
author_facet Quartuccio, Luca
Giovannini, Ivan
Pizzolitto, Stefano
Scarpa, Maurizio
De Vita, Salvatore
author_sort Quartuccio, Luca
collection PubMed
description We report 2 cases of Whipple disease (WD), previously diagnosed as seronegative polyarthritis and treated for several years with immunosuppressive agents, accordingly. Both cases had been treated over years with cDMARDs and bDMARDs. The first patient was a 48-year-old male, who developed a life-threatening disease characterized by fever, significant weight loss, and bloody diarrhoea, supported with RBC transfusions. The second patient was a 55-year-old man, presenting with arthritis, fever, serositis, lymphadenopathy, thoracic rash, and systemic inflammation; at the beginning he was diagnosed as adult onset Still's disease. He was treated with steroids and antitumour necrosis factor agents, but showed no improvement. Both patients were eventually treated with antimicrobial therapy for WD with dramatic improvement and no clinical relapse in 6 months. This paper reviews the literature on WD mimicking chronic inflammatory arthritis. WD may lead to chronic seronegative arthritis that might often be misrecognized. Importantly, patients treated with bDMARDs and glucocorticoids might develop a life-threatening disease. Therefore, WD should be suspected and excluded in patients showing resistance or frequent recurrence of chronic arthritis, if seronegative, under treatment with bDMARDs, especially in the presence of new, unexpected sign and/or symptoms.
format Online
Article
Text
id pubmed-6815603
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-68156032019-11-17 Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents Quartuccio, Luca Giovannini, Ivan Pizzolitto, Stefano Scarpa, Maurizio De Vita, Salvatore Case Rep Rheumatol Case Report We report 2 cases of Whipple disease (WD), previously diagnosed as seronegative polyarthritis and treated for several years with immunosuppressive agents, accordingly. Both cases had been treated over years with cDMARDs and bDMARDs. The first patient was a 48-year-old male, who developed a life-threatening disease characterized by fever, significant weight loss, and bloody diarrhoea, supported with RBC transfusions. The second patient was a 55-year-old man, presenting with arthritis, fever, serositis, lymphadenopathy, thoracic rash, and systemic inflammation; at the beginning he was diagnosed as adult onset Still's disease. He was treated with steroids and antitumour necrosis factor agents, but showed no improvement. Both patients were eventually treated with antimicrobial therapy for WD with dramatic improvement and no clinical relapse in 6 months. This paper reviews the literature on WD mimicking chronic inflammatory arthritis. WD may lead to chronic seronegative arthritis that might often be misrecognized. Importantly, patients treated with bDMARDs and glucocorticoids might develop a life-threatening disease. Therefore, WD should be suspected and excluded in patients showing resistance or frequent recurrence of chronic arthritis, if seronegative, under treatment with bDMARDs, especially in the presence of new, unexpected sign and/or symptoms. Hindawi 2019-10-13 /pmc/articles/PMC6815603/ /pubmed/31737398 http://dx.doi.org/10.1155/2019/3410468 Text en Copyright © 2019 Luca Quartuccio et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Quartuccio, Luca
Giovannini, Ivan
Pizzolitto, Stefano
Scarpa, Maurizio
De Vita, Salvatore
Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents
title Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents
title_full Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents
title_fullStr Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents
title_full_unstemmed Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents
title_short Seronegative Arthritis and Whipple Disease: Risk of Misdiagnosis in the Era of Biologic Agents
title_sort seronegative arthritis and whipple disease: risk of misdiagnosis in the era of biologic agents
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815603/
https://www.ncbi.nlm.nih.gov/pubmed/31737398
http://dx.doi.org/10.1155/2019/3410468
work_keys_str_mv AT quartuccioluca seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents
AT giovanniniivan seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents
AT pizzolittostefano seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents
AT scarpamaurizio seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents
AT devitasalvatore seronegativearthritisandwhipplediseaseriskofmisdiagnosisintheeraofbiologicagents